-
1
-
-
79959453367
-
Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells
-
G. Batman, A.W. Oliver, I. Zehbe, C. Richard, L. Hampson, and I.N. Hampson Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells Antivir. Ther. 16 2011 515 525
-
(2011)
Antivir. Ther.
, vol.16
, pp. 515-525
-
-
Batman, G.1
Oliver, A.W.2
Zehbe, I.3
Richard, C.4
Hampson, L.5
Hampson, I.N.6
-
2
-
-
69949170793
-
The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies
-
P.O. Bauer, and N. Nukina The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies J. Neurochem. 110 2009 1737 1765
-
(2009)
J. Neurochem.
, vol.110
, pp. 1737-1765
-
-
Bauer, P.O.1
Nukina, N.2
-
3
-
-
67649690944
-
Inhibition of Rho kinases enhances the degradation of mutant huntingtin
-
P.O. Bauer, H.K. Wong, F. Oyama, A. Goswami, M. Okuno, Y. Kino, H. Miyazaki, and N. Nukina Inhibition of Rho kinases enhances the degradation of mutant huntingtin J. Biol. Chem. 284 2009 13153 13164
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 13153-13164
-
-
Bauer, P.O.1
Wong, H.K.2
Oyama, F.3
Goswami, A.4
Okuno, M.5
Kino, Y.6
Miyazaki, H.7
Nukina, N.8
-
4
-
-
68049096318
-
The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system
-
M.C. Chiang, H.M. Chen, H.L. Lai, H.W. Chen, S.Y. Chou, C.M. Chen, F.J. Tsai, and Y.J. Chern The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system Hum. Mol. Genet. 18 2009 2929 2942
-
(2009)
Hum. Mol. Genet.
, vol.18
, pp. 2929-2942
-
-
Chiang, M.C.1
Chen, H.M.2
Lai, H.L.3
Chen, H.W.4
Chou, S.Y.5
Chen, C.M.6
Tsai, F.J.7
Chern, Y.J.8
-
5
-
-
30744474942
-
L
-
L Neurobiol. Dis. 21 2006 335 345
-
(2006)
Neurobiol. Dis.
, vol.21
, pp. 335-345
-
-
Chou, A.H.1
Yeh, T.H.2
Kuo, Y.L.3
Kao, Y.C.4
Jou, M.J.5
Hsu, C.Y.6
Tsai, S.R.7
Kakizuka, A.8
Wang, H.L.9
-
6
-
-
45049085458
-
Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation
-
A.H. Chou, T.H. Yeh, P. Ouyang, Y.L. Chen, S.Y. Chen, and H.L. Wang Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation Neurobiol. Dis. 31 2008 89 101
-
(2008)
Neurobiol. Dis.
, vol.31
, pp. 89-101
-
-
Chou, A.H.1
Yeh, T.H.2
Ouyang, P.3
Chen, Y.L.4
Chen, S.Y.5
Wang, H.L.6
-
7
-
-
78651254160
-
P53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons
-
A.H. Chou, A.C. Lin, K.Y. Hong, S.H. Hu, Y.L. Chen, J.Y. Chen, and H.L. Wang p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons Neurochem. Int. 58 2011 145 152
-
(2011)
Neurochem. Int.
, vol.58
, pp. 145-152
-
-
Chou, A.H.1
Lin, A.C.2
Hong, K.Y.3
Hu, S.H.4
Chen, Y.L.5
Chen, J.Y.6
Wang, H.L.7
-
8
-
-
78650613146
-
HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3
-
A.H. Chou, S.Y. Chen, T.H. Yeh, Y.H. Weng, and H.L. Wang HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3 Neurobiol. Dis. 41 2011 481 488
-
(2011)
Neurobiol. Dis.
, vol.41
, pp. 481-488
-
-
Chou, A.H.1
Chen, S.Y.2
Yeh, T.H.3
Weng, Y.H.4
Wang, H.L.5
-
9
-
-
84860660444
-
Toward understanding Machado-Joseph disease
-
M.C. Costa, and H.L. Paulson Toward understanding Machado-Joseph disease Prog. Neurobiol. 97 2012 239 257
-
(2012)
Prog. Neurobiol.
, vol.97
, pp. 239-257
-
-
Costa, M.C.1
Paulson, H.L.2
-
10
-
-
73249130297
-
Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice
-
J. Ding, Q.Y. Li, J.Z. Yu, X. Wang, C.H. Sun, C.Z. Lu, and B.Z. Xiao Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice Mol. Cell. Neurosci. 43 2010 201 208
-
(2010)
Mol. Cell. Neurosci.
, vol.43
, pp. 201-208
-
-
Ding, J.1
Li, Q.Y.2
Yu, J.Z.3
Wang, X.4
Sun, C.H.5
Lu, C.Z.6
Xiao, B.Z.7
-
11
-
-
33745088678
-
Molecular pathogenesis of spinocerebellar ataxias
-
A.M. Duenas, R. Goold, and P. Giunti Molecular pathogenesis of spinocerebellar ataxias Brain 129 2006 1357 1370
-
(2006)
Brain
, vol.129
, pp. 1357-1370
-
-
Duenas, A.M.1
Goold, R.2
Giunti, P.3
-
12
-
-
33750962224
-
Ataxin-3 represses transcription via chromati binding, interaction with histone deacetylase 3, and histone deacetylation
-
B.O. Evert, J. Araujo, A.M. Vieira-Saecker, R.A.I. de Vos, S. Harendza, T. Klockgether, and U. Wüllner Ataxin-3 represses transcription via chromati binding, interaction with histone deacetylase 3, and histone deacetylation J. Neurosci. 26 2006 11474 11486
-
(2006)
J. Neurosci.
, vol.26
, pp. 11474-11486
-
-
Evert, B.O.1
Araujo, J.2
Vieira-Saecker, A.M.3
De Vos, R.A.I.4
Harendza, S.5
Klockgether, T.6
Wüllner, U.7
-
13
-
-
65849122227
-
Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration
-
A.G. Garden, and A.R. La Spada Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration Cerebellum 22 2008 138 149
-
(2008)
Cerebellum
, vol.22
, pp. 138-149
-
-
Garden, A.G.1
La Spada, A.R.2
-
14
-
-
33846192375
-
Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors
-
K.B. Goodman, H. Cui, S.E. Dowdell, D.E. Gaitanopoulos, R.L. Ivy, C.A. Sehon, R.A. Stavenger, G.Z. Wang, A.Q. Viet, Wi. Xu, G. Ye, S.F. Semus, C. Evans, H.E. Fries, L.J. Jolivette, R.B. Kirkpatrick, E. Dul, S.S. Khandekar, T. Yi, D.K. Jung, L.L. Wright, G.K. Smith, D.J. Behm, R. Bentley, C.P. Doe, E. Hu, and D. Lee Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors J. Med. Chem. 50 2007 6 9
-
(2007)
J. Med. Chem.
, vol.50
, pp. 6-9
-
-
Goodman, K.B.1
Cui, H.2
Dowdell, S.E.3
Gaitanopoulos, D.E.4
Ivy, R.L.5
Sehon, C.A.6
Stavenger, R.A.7
Wang, G.Z.8
Viet, A.Q.9
Xu, Wi.10
Ye, G.11
Semus, S.F.12
Evans, C.13
Fries, H.E.14
Jolivette, L.J.15
Kirkpatrick, R.B.16
Dul, E.17
Khandekar, S.S.18
Yi, T.19
Jung, D.K.20
Wright, L.L.21
Smith, G.K.22
Behm, D.J.23
Bentley, R.24
Doe, C.P.25
Hu, E.26
Lee, D.27
more..
-
15
-
-
79959352258
-
A new drug design targeting the adenosinergic system for Huntington's disease
-
N.K. Huang, J.H. Lin, J.T. Lin, C.I. Lin, E.M. Liu, C.J. Lin, W.P. Chen, Y.C. Shen, H.M. Chen, J.B. Chen, H.L. Lai, C.W. Yang, M.C. Chiang, Y.S. Wu, C. Chang, J.F. Chen, J.M. Fang, Y.L. Lin, and Y.J. Chern A new drug design targeting the adenosinergic system for Huntington's disease PLoS One 6 2011 e20934
-
(2011)
PLoS One
, vol.6
, pp. 20934
-
-
Huang, N.K.1
Lin, J.H.2
Lin, J.T.3
Lin, C.I.4
Liu, E.M.5
Lin, C.J.6
Chen, W.P.7
Shen, Y.C.8
Chen, H.M.9
Chen, J.B.10
Lai, H.L.11
Yang, C.W.12
Chiang, M.C.13
Wu, Y.S.14
Chang, C.15
Chen, J.F.16
Fang, J.M.17
Lin, Y.L.18
Chern, Y.J.19
-
16
-
-
0028143527
-
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
-
Y. Kawaguchi, T. Okamoto, M. Taniwaki, M. Aizawa, M. Inoue, S. Katayama, H. Kawakami, S. Nakamura, M. Nishimura, I. Akiguchi, J. Kimura, S. Narumiya, and A. Kakizuka CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 Nat. Genet. 8 1994 221 228
-
(1994)
Nat. Genet.
, vol.8
, pp. 221-228
-
-
Kawaguchi, Y.1
Okamoto, T.2
Taniwaki, M.3
Aizawa, M.4
Inoue, M.5
Katayama, S.6
Kawakami, H.7
Nakamura, S.8
Nishimura, M.9
Akiguchi, I.10
Kimura, J.11
Narumiya, S.12
Kakizuka, A.13
-
17
-
-
0344531010
-
Molecular analysis of Machado-Joseph disease
-
T. Kobayashi, and A. Kakizuka Molecular analysis of Machado-Joseph disease Cytogenet. Genome Res. 100 2003 261 275
-
(2003)
Cytogenet. Genome Res.
, vol.100
, pp. 261-275
-
-
Kobayashi, T.1
Kakizuka, A.2
-
18
-
-
77949775195
-
Repeat expansion disease: Progress and puzzles in disease pathogenesis
-
A.R. La Spada, and J.P. Taylor Repeat expansion disease: progress and puzzles in disease pathogenesis Nat. Rev. Genet. 11 2010 247 258
-
(2010)
Nat. Rev. Genet.
, vol.11
, pp. 247-258
-
-
La Spada, A.R.1
Taylor, J.P.2
-
19
-
-
0037160106
-
Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities
-
F. Li, T. Macfarlan, R.N. Pittman, and D. Chakravarti Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities J. Biol. Chem. 277 2002 45004 45012
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 45004-45012
-
-
Li, F.1
MacFarlan, T.2
Pittman, R.N.3
Chakravarti, D.4
-
20
-
-
70350348368
-
Y-27632 improves rotarod performance and reduces huntingtin levels in R6/2 mice
-
M. Li, Y. Huang, A.A. Ma, E. Lin, and M.I. Diamond Y-27632 improves rotarod performance and reduces huntingtin levels in R6/2 mice Neurobiol. Dis. 36 2009 413 420
-
(2009)
Neurobiol. Dis.
, vol.36
, pp. 413-420
-
-
Li, M.1
Huang, Y.2
Ma, A.A.3
Lin, E.4
Diamond, M.I.5
-
21
-
-
79960668226
-
Polyglutamine diseases: The special case of ataxin-3 and Machado-Joseph disease
-
C.A. Matos, S. de Macedo-Ribeiro, and A.L. Carvalho Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease Prog. Neurobiol. 95 2011 26 48
-
(2011)
Prog. Neurobiol.
, vol.95
, pp. 26-48
-
-
Matos, C.A.1
De MacEdo-Ribeiro, S.2
Carvalho, A.L.3
-
22
-
-
18944372230
-
Rho kinase, a promising drug target for neurological diseases
-
B.K. Mueller, H. Mack, and N. Teusch Rho kinase, a promising drug target for neurological diseases Nat. Rev. Drug Discov. 4 2005 387 398
-
(2005)
Nat. Rev. Drug Discov.
, vol.4
, pp. 387-398
-
-
Mueller, B.K.1
MacK, H.2
Teusch, N.3
-
23
-
-
71749110782
-
The 26S proteasome: From basic mechanisms to drug targeting
-
A. Navon, and A. Ciechanover The 26S proteasome: from basic mechanisms to drug targeting J. Biol. Chem. 284 2009 33713 33718
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 33713-33718
-
-
Navon, A.1
Ciechanover, A.2
-
25
-
-
65849514220
-
SCA3: Neurological features, pathogenesis and animal models
-
O. Riess, U. Rüb, A. Pastore, P. Bauer, and L. Schöls SCA3: neurological features, pathogenesis and animal models Cerebellum 7 2008 125 137
-
(2008)
Cerebellum
, vol.7
, pp. 125-137
-
-
Riess, O.1
Rüb, U.2
Pastore, A.3
Bauer, P.4
Schöls, L.5
-
26
-
-
0035990918
-
The novel and specific Rho-kinase inhibitor (S)-(+)-2 -methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]homopiperazine as a probing molecule for Rho-kinase-involved pathway
-
Y. Sasaki, M. Suzuki, and H. Hidaka The novel and specific Rho-kinase inhibitor (S)-(+)-2 -methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]homopiperazine as a probing molecule for Rho-kinase-involved pathway Pharmacol. Ther. 93 2002 225 232
-
(2002)
Pharmacol. Ther.
, vol.93
, pp. 225-232
-
-
Sasaki, Y.1
Suzuki, M.2
Hidaka, H.3
-
27
-
-
71349088554
-
Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage
-
S. Satoh, A. Hitomi, I. Ikegaki, K. Kawasaki, O. Nakazono, M. Iwasaki, M. Mohri, and T. Asano Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage Brain Res. Bull. 81 2010 191 195
-
(2010)
Brain Res. Bull.
, vol.81
, pp. 191-195
-
-
Satoh, S.1
Hitomi, A.2
Ikegaki, I.3
Kawasaki, K.4
Nakazono, O.5
Iwasaki, M.6
Mohri, M.7
Asano, T.8
-
28
-
-
34249301303
-
Development of Rho-kinase inhibitors for cardiovascular medicine
-
H. Shimokawa, and M. Rashid Development of Rho-kinase inhibitors for cardiovascular medicine Trends Pharmacol. Sci. 28 2007 296 302
-
(2007)
Trends Pharmacol. Sci.
, vol.28
, pp. 296-302
-
-
Shimokawa, H.1
Rashid, M.2
-
29
-
-
33846220180
-
Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons
-
H.L. Wang, C.Y. He, A.H. Chou, T.H. Yeh, Y.L. Chen, and A.H. Li Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons Cell Signal. 19 2007 573 581
-
(2007)
Cell Signal.
, vol.19
, pp. 573-581
-
-
Wang, H.L.1
He, C.Y.2
Chou, A.H.3
Yeh, T.H.4
Chen, Y.L.5
Li, A.H.6
-
30
-
-
79952455313
-
Rho-associated coiled-coil-forming kinases (ROCKs): Potential targets for the treatment of atherosclerosis and vascular disease
-
Q. Zhou, C. Gensch, and J.K. Liao Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease Trends Pharmacol. Sci. 32 2011 167 173
-
(2011)
Trends Pharmacol. Sci.
, vol.32
, pp. 167-173
-
-
Zhou, Q.1
Gensch, C.2
Liao, J.K.3
|